PH12015501705A1 - Methods for producing diketopiperazines and compositions containing diketopiperazines - Google Patents
Methods for producing diketopiperazines and compositions containing diketopiperazinesInfo
- Publication number
- PH12015501705A1 PH12015501705A1 PH12015501705A PH12015501705A PH12015501705A1 PH 12015501705 A1 PH12015501705 A1 PH 12015501705A1 PH 12015501705 A PH12015501705 A PH 12015501705A PH 12015501705 A PH12015501705 A PH 12015501705A PH 12015501705 A1 PH12015501705 A1 PH 12015501705A1
- Authority
- PH
- Philippines
- Prior art keywords
- dkp
- albumin
- diketopiperazines
- methods
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 102000009027 Albumins Human genes 0.000 abstract 6
- 108010088751 Albumins Proteins 0.000 abstract 6
- 230000001225 therapeutic effect Effects 0.000 abstract 3
- 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 abstract 2
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 abstract 2
- RVLCUCVJZVRNDC-IMJSIDKUSA-N 2-[(2s,5s)-5-methyl-3,6-dioxopiperazin-2-yl]acetic acid Chemical compound C[C@@H]1NC(=O)[C@H](CC(O)=O)NC1=O RVLCUCVJZVRNDC-IMJSIDKUSA-N 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 108010038239 aspartyl-alanyl-diketopiperazine Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
- A61K38/385—Serum albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biomedical Technology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361759922P | 2013-02-01 | 2013-02-01 | |
| PCT/US2014/014478 WO2014121210A1 (en) | 2013-02-01 | 2014-02-03 | Methods for producing diketopiperazines and compositions containing diketopiperazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12015501705A1 true PH12015501705A1 (en) | 2015-10-12 |
Family
ID=51263032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12015501705A PH12015501705A1 (en) | 2013-02-01 | 2015-07-31 | Methods for producing diketopiperazines and compositions containing diketopiperazines |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20150366932A1 (enExample) |
| EP (1) | EP2950811A4 (enExample) |
| JP (1) | JP6387019B2 (enExample) |
| KR (1) | KR20150114984A (enExample) |
| CN (1) | CN105188737A (enExample) |
| AU (1) | AU2014212095B2 (enExample) |
| BR (1) | BR112015017958A2 (enExample) |
| CA (1) | CA2900050A1 (enExample) |
| EA (1) | EA030414B1 (enExample) |
| HK (1) | HK1214772A1 (enExample) |
| IL (1) | IL240125A0 (enExample) |
| MX (1) | MX2015009908A (enExample) |
| PH (1) | PH12015501705A1 (enExample) |
| SG (2) | SG11201505715RA (enExample) |
| WO (1) | WO2014121210A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001279313B2 (en) | 2000-08-04 | 2007-03-01 | Ampio Pharmaceuticals, Inc. | Method of using diketopiperazines and composition containing them |
| CA3050734A1 (en) | 2003-05-15 | 2004-12-02 | Ampio Pharmaceuticals, Inc. | Treatment of t-cell mediated diseases |
| WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
| EP2766029B1 (en) | 2011-10-10 | 2020-03-25 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
| EA027343B1 (ru) | 2011-10-10 | 2017-07-31 | Ампио Фармасьютикалз, Инк. | Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования |
| CA2846394A1 (en) | 2011-10-28 | 2013-05-02 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
| BR112015020469A2 (pt) | 2013-03-15 | 2020-01-28 | Ampio Pharmaceuticals Inc | Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo |
| AU2015305611B2 (en) | 2014-08-18 | 2020-04-23 | Ampio Pharmaceuticals, Inc. | Treatment of joint conditions |
| US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
| US10426796B2 (en) * | 2016-06-13 | 2019-10-01 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
| US10456423B2 (en) | 2016-06-13 | 2019-10-29 | SMART SURGICAL, Inc. | Compositions for biological systems and methods for preparing and using the same |
| US20210016273A1 (en) * | 2019-07-19 | 2021-01-21 | University Of Utah Research Foundation | Rapid sperm separation based on sperm morphology and motility |
| US20230074374A1 (en) * | 2020-02-16 | 2023-03-09 | PUR Biologics, Inc | Methods of manufacturing extracellular matrix using aspartyl alanyl diketopiperazine (da-dkp) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2092556A5 (enExample) * | 1970-04-02 | 1972-01-21 | Snam Progetti | |
| US5561115A (en) * | 1994-08-10 | 1996-10-01 | Bayer Corporation | Low temperature albumin fractionation using sodium caprylate as a partitioning agent |
| US5811241A (en) * | 1995-09-13 | 1998-09-22 | Cortech, Inc. | Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones |
| JP2000005569A (ja) * | 1998-06-24 | 2000-01-11 | Asahi Chem Ind Co Ltd | 直列多段濾過法 |
| AU2001279313B2 (en) * | 2000-08-04 | 2007-03-01 | Ampio Pharmaceuticals, Inc. | Method of using diketopiperazines and composition containing them |
| CA3050734A1 (en) * | 2003-05-15 | 2004-12-02 | Ampio Pharmaceuticals, Inc. | Treatment of t-cell mediated diseases |
| CN101279094A (zh) * | 2003-05-15 | 2008-10-08 | Dmi生物科学公司 | T-细胞介导的疾病的治疗 |
| US7790039B2 (en) * | 2003-11-24 | 2010-09-07 | Northwest Biotherapeutics, Inc. | Tangential flow filtration devices and methods for stem cell enrichment |
| US20050197496A1 (en) * | 2004-03-04 | 2005-09-08 | Gtc Biotherapeutics, Inc. | Methods of protein fractionation using high performance tangential flow filtration |
| AU2005277190B2 (en) * | 2004-08-20 | 2011-03-03 | American National Red Cross | Sequential protein isolation and purification schemes by affinity chromatography |
| CN102741280B (zh) * | 2009-10-30 | 2015-12-02 | 诺维信生物制药丹麦公司 | 白蛋白变体 |
| WO2012174472A1 (en) * | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| EA027343B1 (ru) * | 2011-10-10 | 2017-07-31 | Ампио Фармасьютикалз, Инк. | Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования |
| EP2766029B1 (en) * | 2011-10-10 | 2020-03-25 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
| CA2846394A1 (en) * | 2011-10-28 | 2013-05-02 | Ampio Pharmaceuticals, Inc. | Treatment of rhinitis |
-
2014
- 2014-02-03 SG SG11201505715RA patent/SG11201505715RA/en unknown
- 2014-02-03 AU AU2014212095A patent/AU2014212095B2/en not_active Ceased
- 2014-02-03 WO PCT/US2014/014478 patent/WO2014121210A1/en not_active Ceased
- 2014-02-03 BR BR112015017958A patent/BR112015017958A2/pt not_active IP Right Cessation
- 2014-02-03 JP JP2015556207A patent/JP6387019B2/ja not_active Expired - Fee Related
- 2014-02-03 SG SG10201706213RA patent/SG10201706213RA/en unknown
- 2014-02-03 CA CA2900050A patent/CA2900050A1/en not_active Abandoned
- 2014-02-03 US US14/765,018 patent/US20150366932A1/en not_active Abandoned
- 2014-02-03 HK HK16102846.4A patent/HK1214772A1/zh unknown
- 2014-02-03 EA EA201500783A patent/EA030414B1/ru not_active IP Right Cessation
- 2014-02-03 MX MX2015009908A patent/MX2015009908A/es unknown
- 2014-02-03 KR KR1020157023636A patent/KR20150114984A/ko not_active Withdrawn
- 2014-02-03 CN CN201480015923.2A patent/CN105188737A/zh active Pending
- 2014-02-03 EP EP14745933.3A patent/EP2950811A4/en not_active Withdrawn
-
2015
- 2015-07-23 IL IL240125A patent/IL240125A0/en unknown
- 2015-07-31 PH PH12015501705A patent/PH12015501705A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201500783A1 (ru) | 2016-05-31 |
| US20150366932A1 (en) | 2015-12-24 |
| CN105188737A (zh) | 2015-12-23 |
| EP2950811A1 (en) | 2015-12-09 |
| MX2015009908A (es) | 2015-09-24 |
| IL240125A0 (en) | 2015-09-24 |
| EA030414B1 (ru) | 2018-08-31 |
| BR112015017958A2 (pt) | 2017-07-11 |
| KR20150114984A (ko) | 2015-10-13 |
| EP2950811A4 (en) | 2016-06-08 |
| AU2014212095B2 (en) | 2018-07-26 |
| SG11201505715RA (en) | 2015-08-28 |
| HK1214772A1 (zh) | 2016-08-05 |
| CA2900050A1 (en) | 2014-08-07 |
| JP2016511238A (ja) | 2016-04-14 |
| JP6387019B2 (ja) | 2018-09-05 |
| AU2014212095A1 (en) | 2015-09-10 |
| WO2014121210A1 (en) | 2014-08-07 |
| SG10201706213RA (en) | 2017-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015009908A (es) | Metodos para producir dicetopiperazinas y composiciones que contienen dicetopiperazinas. | |
| PH12019500694A1 (en) | Factor viii compositions and methods of making and using the same | |
| EP2470670A4 (en) | COAGULATION FACTOR VII COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF | |
| NZ628126A (en) | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases | |
| NZ705370A (en) | Fcγriib-specific fc region variant | |
| EA201190326A8 (ru) | Полипептиды гормона роста и способы их получения и применения | |
| WO2013040093A3 (en) | Glucagon-like peptide-2 compositions and methods of making and using same | |
| WO2013184938A3 (en) | Fusion polypeptides comprising mucin-domain polypeptide linkers | |
| SG10201906859PA (en) | Novel proteins specific for angiogenesis | |
| MX2014004359A (es) | Proteina naglu humana recombinante y usos de la misma. | |
| EA201270225A1 (ru) | СОЕДИНЕНИЯ ДЛЯ УМЕНЬШЕНИЯ ПРОДУКЦИИ β-АМИЛОИДА | |
| MX2011008094A (es) | Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos. | |
| UA107180C2 (uk) | Туберкульозний білок rv1753c, композиція, що його містить, та застосування | |
| MX336391B (es) | Metodos y composiciones que usan polipeptidos de fusion de fgf23. | |
| MX2008012748A (es) | Un proceso para la concentracion de un polipeptido. | |
| IN2014DN09815A (enExample) | ||
| MY200710A (en) | Novel fusion protein specific for cd137 and pd-l1 | |
| MX2023003348A (es) | Compuestos y composiciones como moduladores de señalización tlr. | |
| AR071232A1 (es) | Proteina hibrida usada como vacuna contra toxinas shiga de e. coli | |
| NZ742660A (en) | Variants of chymosin with improved milk-clotting properties | |
| MX2016007407A (es) | Peptidos resistentes a proteasa. | |
| MX2021005346A (es) | Constructos de suministro para transcitosis y metodos relacionados. | |
| EA202192460A1 (ru) | Синтетические нейромодуляторные пептиды | |
| NZ596501A (en) | Casb7439 constructs | |
| MX2023003836A (es) | Metodos para reducir el contenido de proteinas de celula huesped en procesos de purificacion de proteinas. |